Notably, we made the novel finding that T2D risk, as conferred by HNF1A, GCK, and SLC30A8 genetic variants, may also be modified in the presence/absence of obesity. The gene discussed is GCK; the disease is obesity due to melanocortin 4 receptor deficiency.